The Alzheimer’s Paradox: Early Diagnosis Is Here. Effective Treatment Isn’t

In 2026, a blood test can detect biological signs of Alzheimer’s disease years before memory problems become apparent. The same test can help determine who qualifies for the first drugs capable of slowing the disease. Researchers can now track the proteins responsible for damaging the brain, identify people at elevated risk, and intervene while patients are still functioning independently. Yet there is no cure. The benefits of existing treatments remain modest, their risks are significant, and scientists are increasingly questioning whether Alzheimer’s should even be understood as a single disease.

Start slideshow
Click "Allow" to continue